Estructura del grupo
28 empresas en 12 países
Cargando…
28 empresas en 12 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 573
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| 2IN1 MEN ADVANCED SERIES BOURBON1 % / w/w · Shampoo | Pyrithione zinc | Canadá | No comercializado | 2020 |
| 2IN1 MEN ADVANCED SERIES CHARCOAL1 % / w/w · Shampoo | Pyrithione zinc | Canadá | No comercializado | 2019 |
| 2IN1 MEN ADVANCED SERIES SAGE & MINT1 % / w/w · Shampoo | Pyrithione zinc | Canadá | No comercializado | 2020 |
| 7 IN ONE TONE CORRECTING CC CREAM WITH SPF2 % / w/w + 3 % / w/w + 3 % / w/w · Cream | Avobenzone, Octisalate, Octocrylene | Canadá | Comercializado | 2021 |
| AGE DEFYING ANTI-WRINKLE LOTION WITH SPF3 % / w/w + 4 % / w/w + 4.5 % / w/w + 2.6 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Comercializado | 2016 |
| AGE DEFYING CLASSIC LOTION WITH SPF6 % / w/w + 3 % / w/w · Lotion | Octinoxate, Zinc oxide | Canadá | Comercializado | 2017 |
| ALGINAC | Vitamin b12, Vitamin b1, Vitamin b6, Diclofenac | Brasil | Autorizado | 2019 |
| ALOE VERA 2IN11 % / w/w · Shampoo | Pyrithione zinc | Canadá | No comercializado | 2020 |
| BARE MINIMAL INGREDIENTS 2IN1 SHAMPOO PURE CLEAN1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2025 |
| BARE MINIMAL INGREDIENTS ITCH CONTROL SERUM0.1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2026 |
| BARE MINIMAL INGREDIENTS SHAMPOO ITCH CONTROL1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2025 |
| BARE MINIMAL INGREDIENTS SHAMPOO PURE CLEAN1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2024 |
| BARE MINIMAL INGREDIENTS SHAMPOO SENSITIVE SCALP CARE1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2026 |
| BARE MINIMAL INGREDIENTS SHAMPOO SOOTHING HYDRATION1 % / w/w · Shampoo | Pyrithione zinc | Canadá | Comercializado | 2024 |
| BRIGHTENING DAILY FACIAL MOISTURIZER WITH SPF3 % / w/w + 9 % / w/w + 4.5 % / w/w + 6 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Autorizado | |
| CITONEURIN | Vitamin b12, Vitamin b1, Vitamin b6 | Brasil | Autorizado | 2019 |
| COMPLETE + FACIAL MOISTURIZER WITH SPF BROAD SPECTRUM SPF 403 % / w/w + 10 % / w/w + 5 % / w/w + 9 % / w/w · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Comercializado | 2024 |
| COMPLETE HYDRATING CREAM WITH SPF3 % / w/w + 4 % / w/w + 4.5 % / w/w + 2.6 % / w/w · Cream | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Comercializado | 2017 |
| COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM 15 FOR COMBINATION/OILY SKIN3 % + 4 % + 4.5 % + 2.6 % · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Comercializado | 2017 |
| COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 153 % + 4 % + 4.5 % + 2.6 % · Lotion | Avobenzone, Homosalate, Octisalate, Octocrylene | Canadá | Comercializado | 2017 |
| COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 15 SENSITIVE6 % / w/w + 3 % / w/w · Lotion | Octinoxate, Zinc oxide | Canadá | Comercializado | 2018 |
| COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 307.5 % / w/w + 2.5 % / w/w + 2.5 % / w/w + 6.9 % / w/w · Lotion | Octinoxate, Octisalate, Octocrylene, Zinc oxide | Canadá | Comercializado | 2018 |
| CREST PRO-HEALTH COMPLETE CLEAN0.07 % / w/w · Mouthwash | Cetylpyridinium | Canadá | Comercializado | 2026 |
| CREST PRO-HEALTH GERM GUARD0.07 % / w/w · Mouthwash | Cetylpyridinium | Canadá | Comercializado | 2021 |
| CREST PRO-HEALTH GUM & BREATH PURIFY0.07 % / w/w · Mouthwash | Cetylpyridinium | Canadá | Comercializado | 2021 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 515 | 219 | 296 | EmpresasTodos los medicamentos |
| Brasil | 38 | 13 | 25 | EmpresasTodos los medicamentos |
| Países Bajos | 7 | 7 | 0 | EmpresasTodos los medicamentos |
| Singapur | 6 | 6 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 3 | 3 | 0 | EmpresasTodos los medicamentos |
| España | 2 | 1 | 1 | EmpresasTodos los medicamentos |
| Arabia Saudí | 2 | 2 | 0 | EmpresasTodos los medicamentos |
También en los registros de Colombia, Italia, Malasia, Reino Unido, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licencia: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Procter en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaLicencia: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.